| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5814995 | Neuropharmacology | 2013 | 13 Pages |
Abstract
⺠Agents acting on mGlu2/3 and mGlu5 receptors exhibit antidepressant effects. ⺠mGlu2/3 and mGlu5 receptor antagonists share neural mechanisms with ketamine. ⺠mGlu2/3 and mGlu5 receptors are useful targets for drug discovery for depression.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Shigeyuki Chaki, Yukio Ago, Agnieszka Palucha-Paniewiera, Francesco Matrisciano, Andrzej Pilc,